Predictors of microvascular complications in type 1 diabetic patients at onset: The role of metabolic memory

被引:20
作者
Giordano, Carla [1 ]
Amato, Marco Calogero [1 ]
Ciresi, Alessandro [1 ]
Citarrella, Roberto [1 ]
Mantione, Lucilla [1 ]
Accidenti, Maria [1 ]
Panto, Felicia [1 ]
Guarnotta, Valentina [1 ]
Allotta, Maria Luisa [1 ]
Criscimanna, Angela [1 ]
Galluzzo, Aldo [1 ]
机构
[1] Univ Palermo, Endocrinol Sect, Ctr Riferimento Reg Diag & Cura Endocrinopatie Au, Dipartimento Med Interna & Med Sperimentale DIBIM, I-90127 Palermo, Italy
关键词
Type; 1; diabetes; Metabolic memory; HbA1c levels; Nephropathy; Retinopathy; Microalbuminuria; BETA-CELL FUNCTION; GLYCEMIC CONTROL; INSULIN-SECRETION; C-PEPTIDE; RETINOPATHY; MICROALBUMINURIA; RISK; NEPHROPATHY; PROGRESSION; GLUCOSE;
D O I
10.1016/j.ejim.2011.02.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Several epidemiological studies showed a close association between metabolic control and microvascular complications in type 1 Diabetes Mellitus (T1DM). The aim of our longitudinal observational study was to evaluate the predictive role of the main clinical and biochemical parameters in determining microvascular complications. Methods: 376 T1DM patients, hospitalized in our division from 1991 to 2005 (mean follow-up = 10.93 +/- 4.26 years) were studied. Stepwise Cox regression analysis was used to identify the influence of residual beta-cell function, beta-cell autoimmunity, HbA1c levels and other clinical and laboratory parameters in the development of microalbuminuria and retinopathy. Results: The probability of developing microalbuminuria was higher in males than in females (HR 1.82; 95% CI 1.01-3.28; p = 0.044), in patients with higher mean HbA1c values (HR 2.80; 95% CI 1.63-4.83; p < 0.001), longer duration of disease (HR 1.98; 95% CI 1.10-3.57; p = 0.022) and younger age of diabetes onset (HR 0.53; 95% CI 0.03-0.92; p = 0.026). An increased probability of developing retinopathy was found in patients with higher mean HbA1c levels during follow-up (HR 2.35; 95% CI 1.34-4.12, p = 0.003), as well as at onset (HR 1.85; 95% CI 1.06-3.24; p = 0.030). Conclusions: Our study suggests that among the clinical, metabolic, immunological and biochemical factors evaluated at onset, only HbA1c is predictive for the microangiopathy development in T1DM. (C) 2011 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:266 / 274
页数:9
相关论文
共 51 条
  • [1] Inverse relationship between GAD65 antibody levels and severe retinopathy in younger type 1 diabetic patients
    Agardh, D
    Agardh, E
    Landin-Olsson, M
    Gaur, LK
    Agardh, CD
    Lernmark, A
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1998, 40 (01) : 9 - 14
  • [2] β-Cell Mass and Type 1 Diabetes Going, Going, Gone?
    Akirav, Eitan
    Kushner, Jake A.
    Herold, Kevan C.
    [J]. DIABETES, 2008, 57 (11) : 2883 - 2888
  • [3] Standards of Medical Care in Diabetes-2009
    不详
    [J]. DIABETES CARE, 2009, 32 : S13 - S61
  • [4] [Anonymous], 1995, DIABETES, V44, P968
  • [5] [Anonymous], 1991, Diabet Med, V8, P263
  • [6] Glycemic control and prognosis in type I diabetic patients with microalbuminuria
    Bojestig, M
    Arnqvist, HJ
    Karlberg, BE
    Ludvigsson, J
    [J]. DIABETES CARE, 1996, 19 (04) : 313 - 317
  • [7] The "Metabolic Memory": Is More Than Just Tight Glucose Control Necessary to Prevent Diabetic Complications?
    Ceriello, Antonio
    Ihnat, Michael A.
    Thorpe, Jessica E.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) : 410 - 415
  • [8] LONG-TERM GLYCEMIC CONTROL AND KIDNEY-FUNCTION IN INSULIN-DEPENDENT DIABETES-MELLITUS
    DAHLJORGENSEN, K
    BJORO, T
    KIERULF, P
    SANDVIK, L
    BANGSTAD, HJ
    HANSSEN, KF
    [J]. KIDNEY INTERNATIONAL, 1992, 41 (04) : 920 - 923
  • [10] The impact of a family history of Type II (non-insulin-dependent) diabetes mellitus on the risk of diabetic nephropathy in patients with Type I (insulin-dependent) diabetes mellitus
    Fagerudd, JA
    Pettersson-Fernholm, KJ
    Grönhagen-Riska, C
    Groop, PH
    [J]. DIABETOLOGIA, 1999, 42 (05) : 519 - 526